Catalent Pharma Solutions LLC

  • Home
  • Catalent Pharma Solutions LLC

Catalent Pharma Solutions LLC Championing the missions that matter™. Catalent is your trusted partner in transforming lives. Catalyst + Talent. Our name combines these ideas. Catalent develops.

Every medicine, therapy, and product we help develop, manufacture, and deliver reflects our commitment to put patients first. From drug and biologic development services to delivery technologies to supply solutions, we are the catalyst for your success. With time-tested experience in development sciences, delivery technologies, and multi-modality manufacturing, Catalent supports the acceleration o

f development programs and the launch of more than a hundred new products every year. With our broad range of expert services we drive faster, more efficient development timelines to help you take more molecules to market and create more effective products. Catalent delivers. As the world leader in drug delivery innovations, we have a proven record of enhancing bioavailability, solubility and permeability, improving ease and route of administration, and increasing patient compliance for better treatments. Catalent supplies. Globally positioned to serve all your manufacturing and commercial packaging needs, we provide integrated solutions to take your product from design, to clinical trial, to plant, and to pharmacy.

Boston, we're ready.Our Catalent experts are at the Bioprocessing Summit this week, connecting with innovators who are s...
11/08/2026

Boston, we're ready.

Our Catalent experts are at the Bioprocessing Summit this week, connecting with innovators who are shaping the future of biologics. Whether you're advancing a promising molecule or planning for commercialization, let's talk about how the right development and manufacturing strategy can accelerate your path forward.

See you at the summit.

Good music. Great food. Even better company.Catalent's 21st Annual Blues Fest returns to San Diego on September 18, 2026...
11/08/2026

Good music. Great food. Even better company.

Catalent's 21st Annual Blues Fest returns to San Diego on September 18, 2026, and we're excited to celebrate another incredible year with our customers, partners, employees, friends and family.

Expect an evening filled with: Grammy Award-winning blues from Fuzzy Rankins and the Band, mouthwatering BBQ from Abby's Texas BBQ, local craft beer, cocktails, wine, and refreshments. We will also have activities for all ages, including caricature artists, face painting, balloon artists, a bounce house, shaved ice, and more!

Blues Fest has become a cherished tradition that brings our community together to celebrate partnership, collaboration, and shared success. We look forward to another unforgettable evening of music, connection, and appreciation.

Register here: https://ow.ly/lbfq50Zyh7E

11/08/2026

A persistent challenge in biologics: difficult-to-express molecules like bispecific antibodies and complex recombinant proteins that often lead to low titers, extended timelines, and scalability risk.

In this clip, Nick Sanek, PhD walks through how GPEx® Lightning takes a fundamentally different approach to cell line development.

Watch the full session, including the case studies, to see how GPEx® Lightning supports reliable development of next-generation biologics from discovery through commercial: https://ow.ly/GIUg50Zyh31

10/08/2026

In a recent interview with Drug Discovery Network, Philip Wills, Chief Commercial Officer at Catalent, discusses how the gene therapy industry has evolved from a promising scientific concept to a growing reality for patients with rare genetic diseases.

Key insights include:

The industry's progression from a handful of clinical trials to multiple approved therapies

The importance of building commercial manufacturing and regulatory readiness earlier in development

Lessons learned from first-generation gene therapies that are helping shape the next wave of programs

Why a Patient First mindset remains essential as the industry continues to mature and scale

🎥 Watch the full interview here: https://ow.ly/6tjB50Zy8Pe

Hear Philip's perspective on the evolution of gene therapy manufacturing, the bottlenecks that still need to be overcome, and what it will take to bring transformative therapies to more patients worldwide.

10/08/2026

We are excited to host an in-person Industry Day at our Cell Therapy Center of Excellence in Princeton, NJ on August 20th.

Come join us for an exclusive presentation, “Evidence, Plausibility, and FDA Approval,” by Wilson W. Bryan, MD, Regulatory Consultant and former Director of the FDA's Center for Biologics Evaluation and Research (CBER) Office of Tissues and Advanced Therapies (OTAT).

Dr. Bryan will discuss traditional approval, accelerated approval, and the Plausible Mechanism Framework, offering valuable insights into today's evolving regulatory landscape.

The program will also feature a presentation by Sharon Anderson, Vice President, Scientific Affairs, Alliance for Regenerative Medicine (ARM), titled “Advancing CAR-T Access: From Challenges to Opportunity” exploring key barriers and emerging solutions to expand patient access to CAR-T therapies.

Attendees will also have the opportunity to engage in discussions on the current state of cell therapy, learn about our cell therapy capabilities in Princeton, and tour our state-of-the-art facility. Lunch and networking opportunities will be provided.

We look forward to connecting with industry colleagues and exploring the future of cell therapy together.

There's just 10 days to go! Reserve your spot now: https://ow.ly/5fMa50Zy401

A single API may need to perform across oral, inhaled, nasal, or injectable delivery routes.Discover how micronization h...
07/08/2026

A single API may need to perform across oral, inhaled, nasal, or injectable delivery routes.

Discover how micronization helps overcome solubility challenges, optimize performance, and create new formulation possibilities throughout the drug development lifecycle: https://ow.ly/re0250ZxoQS

Looking to expand into high-growth wellness spaces with consumer preferred dose forms?Catalent is a market leader in sof...
07/08/2026

Looking to expand into high-growth wellness spaces with consumer preferred dose forms?

Catalent is a market leader in soft chews and gummies - bringing together deep expertise in taste, texture, and flavor systems to solve even the most complex formulations. From sports & performance nutrition to women’s health and GLP-1 user support, our proven platforms help brands launch faster and stand out in the market.

Consumer-preferred formats.

Challenging actives. Expertly delivered.

Explore what’s possible 👉 https://ow.ly/Zwnk50Zx3Lf

Now more than ever, innovative biologics are advancing quickly and promise to address unmet needs across a number of cha...
06/08/2026

Now more than ever, innovative biologics are advancing quickly and promise to address unmet needs across a number of challenging disease areas. At Catalent, we are committed to making it easy for Biologics customers to find information that is tailored to their specific needs.

That's why I'm excited about the launch of our redesigned Catalent.com. The new digital experience helps customers more easily explore our capabilities, connect with experts and find solutions across the development lifecycle.

Explore the new experience: https://ow.ly/Xpfp50Zv26K

From prescription medicines to consumer health products, today's innovators need faster access to information, expertise...
05/08/2026

From prescription medicines to consumer health products, today's innovators need faster access to information, expertise and trusted partners.

Our newly redesigned Catalent.com was built around that need. The site offers a simplified, customer-focused experience that makes it easier to explore solutions that best support development and commercial goals.

This launch reflects our commitment to continually improving how we serve customers, helping them focus on bringing life-saving medicines to patients in need.

Explore the new experience: https://ow.ly/Zhxz50Zwtiq

04/08/2026

For emerging biopharma companies, early development decisions can have a lasting impact on program success.

In this BioPharm International expert discussion, Laura Daley explores what it takes to support rapid candidate identification and establish a strong foundation for future development and manufacturing activities.

▶️ Watch the discussion: https://ow.ly/iNcW50ZwfmW

Address

NJ

Telephone

+17325376200

Website

Alerts

Be the first to know and let us send you an email when Catalent Pharma Solutions LLC posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Catalent Pharma Solutions LLC:

Shortcuts

  • Want your business to be the top-listed Engineering Company?

Share